Joanne Palmisano, MD, FACP, FRAPS Dr. Palmisano is a global regulatory leader with extensive biopharmaceutical drug development expertise in small molecule and biologics in multiple therapeutic areas. As Vice President Regulatory Affairs, Boehringer Ingelheim Pharmaceuticals Inc., she is responsible for leadership of the US Regulatory Affairs organization. Prior roles in industry include Assistant VP, Global Regulatory Affairs, Wyeth (now Pfizer), and Senior Medical Director of Clinical Development for Cardiovascular/ Lipids & Endocrinology, Merck. She serves as an ICH expert working group member for E8: Clinical Trials (E8) and E11: Pediatric Drug Development. Dr. Palmisano is a RAPS Distinguished Fellow.